MRNA Keeps Climbing After Major Catalyst

The market has become increasingly selective, making sustained price strength more meaningful when a stock can absorb a major catalyst and continue advancing rather than surrendering its gains. Moderna Inc. (MRNA) caught our attention after positive mid-August clinical trial results for its melanoma vaccine helped propel shares higher, with the stock subsequently carving out higher highs, higher lows, and fresh 52-week highs. Beneath that price action, MRNA has also maintained a PowerTrend Buy signal since December 2025, confirming that its one-month price remains above its 10-month simple moving average (SMA). This long-term trend system helps identify stocks with sustained buying pressure behind them, and with the signal still intact and strengthening, MRNA is showing both improving momentum and longer-term technical support. This is a unique relative outperformer, away from the Tech complex, that has earned a spot on our buy list.

🚨 Your next trade idea could be waiting this weekend… Get the latest Weekend Winners alerts with the trade setup, entry point, and exit strategy spelled out. Click Here to Get Access Today! 🔔

With shares trading above $197, buying the stock outright requires a meaningful capital commitment, while purchasing a standalone call can mean paying a substantial premium for time value. An in-the-money (ITM) call debit spread offers another route, combining two call options to establish bullish exposure with a defined initial cost and the potential to benefit even if the stock pulls back moderately. In the current setup we’re tracking, the spread offers 66.7% profit potential if MRNA finishes at expiration up, flat, or down as much as 10.0%, with an entry cost of just $300. Of course the actual outcome depends on the spread’s terms and MRNA’s price at expiration, and like all trades, this setup still does carry risk.

Finding promising setups is one challenge; turning them into a practical trading plan or building another potential income stream is where many investors need a clearer process, which is why our Optioneering Newsletter delivers multiple actionable trade ideas each week, complete with technical analysis, detailed entry information, and strategy insights to help you evaluate the opportunities for yourself. Start your first month for just $1 and see how our team approaches finding our top trade ideas—Click Here to begin your trial today!

Wishing You the Best in Investing Success,